Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Minority Interest: 2018-2020

Historic Minority Interest for Amphastar Pharmaceuticals (AMPH) over the last 3 years, with Dec 2020 value amounting to $46.4 million.

  • Amphastar Pharmaceuticals' Minority Interest rose 1.06% to $45.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $45.2 million, marking a year-over-year increase of 1.06%. This contributed to the annual value of $46.4 million for FY2020, which is 0.55% up from last year.
  • According to the latest figures from FY2020, Amphastar Pharmaceuticals' Minority Interest is $46.4 million, which was up 0.55% from $46.2 million recorded in FY2019.
  • In the past 5 years, Amphastar Pharmaceuticals' Minority Interest ranged from a high of $46.4 million in FY2020 and a low of $31.9 million during FY2018.
  • For the 3-year period, Amphastar Pharmaceuticals' Minority Interest averaged around $41.5 million, with its median value being $46.2 million (2019).
  • Data for Amphastar Pharmaceuticals' Minority Interest shows a peak YoY spiked of 44.60% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Amphastar Pharmaceuticals' Minority Interest stood at $31.9 million in 2018, then soared by 44.60% to $46.2 million in 2019, then increased by 0.55% to $46.4 million in 2020.